The 2012 Landscape of I.V. Medication Safety: Processes, Tools, and Training

Activity Overview

Please read the following information about this continuing pharmacy education (CPE) activity before accessing the presentations using the link located at the bottom of this page.

Release Date: February 15, 2013          Expiration Date: March 3, 2014

Accreditation for Pharmacists

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 2 hours (0.2 CEUs) of continuing pharmacy education credit (ACPE activity #0204-0000-12-436-H05-P).

Methods and Format

This is an online activity consisting of audio and slides, an assessment (post-test), and a course evaluation. Participants should claim continuing education credit for this internet-based educational activity only if they have not claimed credit for the live activity. Participants must view the entire presentation, take the activity assessment, and complete the course evaluation to receive continuing education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing education credit immediately. The estimated time to complete this activity is 2 hours. This activity is provided free of charge.

Target Audience

This continuing pharmacy education activity was planned to meet the needs of all pharmacists, especially those who are interested in the safe use of intravenous medications.

Activity Content

Safe use of i.v. medications in the hospital setting remains a challenge, especially in light of the increasing complexity of therapies, unprecedented medication shortages, evolving technologies to support sterile compounding, and lack of pharmacists with knowledge and skills in this specialized area. National efforts to improve the safety of i.v. medications continue to evolve. The compounding of i.v. medications also continues to present patient safety challenges. This educational activity will examine national efforts in improving i.v. medication safety, focusing on innovation in care and overcoming challenges and unintended consequences associated with complex workflow processes. In addition, faculty will present creative ideas for education that can be implemented to avoid errors and promote safety.

Learning Objectives

After attending this application-based educational activity, participants should be able to

  • Summarize national efforts for improving i.v. medication safety.
  • Apply strategies for minimizing risk of intravenous medication errors.
  • Describe educational methods that can be used to train pharmacists about safe i.v. preparation.
  • Describe human factors and workflow processes that impact i.v. safety.

Faculty

Rita Shane, Pharm.D., FASHP, FCSHP, Activity Chair
Director, Pharmacy Services
Cedars-Sinai Medical Center
Assistant Dean, Clinical Pharmacy
UCSF School of Pharmacy
Los Angeles, California

Rita Shane, Pharm.D., FASHP, FCSHP, is Director of Pharmacy Services at Cedars- Sinai Medical Center, a 950-bed acute, tertiary care, teaching institution in Los Angeles, California, and Assistant Dean, Clinical Pharmacy Services, at the University of California, San Francisco (UCSF), School of Pharmacy.

Dr. Shane has been recognized for her passion for the profession. Most recently, she received the 2012 Harvey A. K. Whitney Award. She is also the recipient of the 2007 California Society of Health-System Pharmacists (CSHP) Pharmacist of the Year Award and the 2007 Distinguished Service Award from the American Society of Health-System Pharmacists (ASHP) Section of Pharmacy Practice Managers. Dr. Shane was the 2005 recipient of the ASHP Distinguished Leadership Award and the 1995 recipient of the John Webb Visiting Professorship in Hospital Pharmacy for management excellence.

Dr. Shane is a co-investigator in two research studies in collaboration with the UCSF School of Pharmacy and approved by the California State Board of Pharmacy to demonstrate the safety and importance of allowing technicians to check technician-filled medication cassettes in hospitals. She also worked collaboratively with CSHP to author language in support of this regulatory change which was approved by the State of California effective in January 2007. Dr. Shane was co-investigator of a 2000 National Patient Safety Foundation Research Award to study the impact of dedicated medication nurses on the rate of medication administration errors in a randomized, controlled trial, the results of which were subsequently published in the Archives of Internal Medicine.

Dr. Shane recently served as the United States facilitator at the Global Conference on the Future of Hospital Pharmacy held during the 68th Congress of the International Pharmaceutical Federation and was responsible for reviewing the international literature on the subject of medication administration. She is an investigator in a multicenter study of medications errors recovered by emergency department pharmacists which was published in the Annals of Emergency Medicine. Throughout her career, Dr. Shane has participated on committees and task forces at the state and national level. She recently was a member of the American Hospital Association Committee on Health Professions and the National Quality Forum Patient Safety Advisory Committee. She is the ASHP representative to The Joint Commission Hospital Professional Technical Committee. She has presented at local, state, national, and international meetings and has published a number of papers in the pharmacy literature including one of the background papers for the recent ASHP Pharmacy Practice Model Summit.

Luci A. Power, M.S., B.S.Pharm.
Senior Pharmacy Consultant
Power Enterprises
San Francisco, California

Luci A. Power, M.S., B.S.Pharm., is an independent lecturer and consultant on pharmacy intravenous (i.v.) and hazardous drug systems. Prior to this role, Ms. Power served in a variety of capacities at the University of California Medical Center in San Francisco Department of Pharmaceutical Services for over 25 years. She was Senior Pharmacist and Manager of I.V. Additive Services, where she was responsible for the compounding of inpatient i.v. therapy and developed chemotherapy and other hazardous drug compounding services for both inpatients and outpatients. As Senior Pharmacist and Manager of Parenteral Support Services, Ms. Power designed, implemented, and managed an off-campus, USP Chapter <797> -compliant compounding center producing TPN and batch i.v. doses for two campuses, as well as supporting the continuous renal replacement therapy (CRRT) service.

Ms. Power has been a member of the American Society of Health-System Pharmacists (ASHP) for over 30 years. She is a primary author of both the 1985 and 1990 ASHP Technical Assistance Bulletins on Handling Cytotoxic and Hazardous Drugs; lead author of the 2006 ASHP Guidelines on Handling Hazardous Drugs; and first author of the ASHP Safe Handling of Hazardous Drugs Video Training Program. Ms. Power is also a contributing author to the second and third editions of ASHP’s text entitled, Compounding Sterile Preparations.

Ms. Power is an original member of the National Institute for Occupational Safety and Health (NIOSH) working group on hazardous drugs. As the group leader for the Work Practices small group, she was an author of the 2004 NIOSH Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings.

Ms. Power has research interests in closed system transfer devices and has worked with i.v. robotics for the safe compounding of hazardous and non-hazardous drugs. She serves on several advisory boards for new technology to improve both patient and worker safety. She has presented numerous programs on hazardous drugs, i.v. therapy, USP Chapter <797>, i.v. robotics, and errors in drug therapy.

Steven R. Abel, Pharm.D., FASHP
Associate Vice Provost for Faculty Affairs
Purdue University
West Lafayette, Indiana

Steven R. Abel, Pharm.D., FASHP, is Associate Vice Provost for Faculty Affairs, Purdue University, Associate Dean for Clinical Programs and Bucke Professor of Pharmacy Practice, Purdue University College of Pharmacy. He served as Head, Department of Pharmacy Practice, from 1996 to 2012. Dr. Abel received his Bachelor of Science in Pharmacy and Doctor of Pharmacy degrees from Purdue University, and he completed residency training at Mayo Medical Center. He completed an academic leadership fellowship through the Committee on Institutional Cooperation in 2007-2008 and an inaugural Purdue University Provost fellowship focused on faculty affairs in 2009-2010. 

Dr. Abel is passionate about student education, leadership development, and mentorship. His research focuses on the development, implementation, and evaluation of progressive pharmacy services, student enhancement of pharmacy practice, patient safety, and interprofessional collaborative strategies to improve the medication use process in any setting. Dr. Abel developed the only fully immersive USP Chapter <797> -compliant virtual cleanroom, based on video game technology, used for student education.

Dr. Abel led the team that implemented international collaboration between the Purdue University College of Pharmacy, Indiana University School of Medicine, and Moi University in Eldoret, Kenya.  Currently, two full-time faculty members sustain the most comprehensive international initiative associated within a college of pharmacy in the United States. He also specializes in ocular pharmacology. Dr. Abel has a history of active service in various pharmaceutical organizations, including the Indiana Pharmacists Alliance, American Society of Health-System Pharmacists, American College of Clinical Pharmacy, American Association of Colleges of Pharmacy, and International Pharmaceutical Federation.

Disclosure Statement

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Guidelines for Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on presentations.

All faculty and planners for ASHP Advantage education activities are qualified and selected by ASHP Advantage and required to disclose any relevant financial relationships with commercial interests. ASHP Advantage identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity.

The faculty and planners report the following relationships:

Rita Shane, Pharm.D., FASHP, FCSHP
Dr. Shane declares that she has no relationships pertinent to this activity.

Luci A. Power, M.S., B.S.Pharm.
Ms. Power declares that she serves on the scientific advisory board and as a consultant for Intelligent Hospital Systems, has a royalty agreement for ChemoPlus Training Kit with Covidien Chemo Protection, and is a stockholder and consultant with S.E.A. Medical Systems, Inc.

Steven R. Abel, Pharm.D., FASHP
Dr. Abel declares that he has no relationships pertinent to this activity.

Kristi N. Hofer, Pharm.D.
Dr. Hofer declares that she has no relationships pertinent to this activity.

ASHP staff has no relevant financial relationships to disclose.

Agenda (120 minutes total)*

The Evolution of I.V. Safety: What Improvements Have Been Made Since the 2008 Safety Summit?
Rita Shane, Pharm.D., FASHP, FCSHP
(35 minutes)

Meeting the Challenge of I.V. Safety
Luci A. Power, M.S., B.S.Pharm.
(35 minutes)

Back to Basics: Innovative Strategies for Teaching the Principles of Safe Medication Compounding
Steven R. Abel, Pharm.D., FASHP
(35 minutes)

Questions and Answers
All Faculty
(optional, 15 minutes)

Launch Presentation

*Allow additional time to complete the assessment and evaluation.

Download Assessment and Handout

Print the assessment (post-test) and handout of slides for your reference; however, your assessment must be submitted online.

Process CE

When you reach the end of the activity, follow instructions to complete the online process (i.e., take assessment test and complete evaluation) and obtain CE credit.